Calibrate launched as a metabolic health company built around GLP-1 medications paired with intensive lifestyle coaching. The model was ambitious: a year-long program combining prescription GLP-1 therapy with one-on-one health coaching, food and sleep tracking, and deep insurance integration.

That last piece turned out to be the fatal flaw. Calibrate's business model depended on patients using insurance to cover GLP-1 prescriptions like Ozempic and Wegovy. When insurers tightened coverage criteria and employers started dropping GLP-1 benefits, the patient acquisition pipeline dried up. Operational costs became unsustainable on a cash-pay basis, and the company closed in 2025.

For patients who were mid-program, the disruption was real. Prescriptions were interrupted. Coaching relationships ended without warning. It was a sharp reminder that any telehealth program built around insurance access is only as stable as the insurer's willingness to keep paying.

Found is still operating. It positions itself as a personalized weight care platform combining prescription medication with behavioral coaching. In 2026, the program includes access to GLP-1 medications — oral Wegovy options and injectable formulations — alongside app-based coaching and provider check-ins.

Pricing runs $199 to $299 per month for oral medication programs and $300-plus per month for injectable GLP-1 options, putting Found firmly in the premium tier of the telehealth weight loss market.

What Found Does Well

Found's coaching layer is more structured than most competitors. The platform integrates behavioral health tools alongside prescription management, which appeals to patients who want more than a monthly prescription refill. The app experience is polished, and the program is designed to support habit change alongside medication — not just hand you a prescription and wish you luck.

Where Found Falls Short

The price is a genuine barrier. At $199 to $299 per month before medication costs, Found sits at or above the budget ceiling for a large share of cash-pay patients. If you're working with $150 to $400 per month total, the coaching program alone can consume most of that range before you've accounted for the medication itself.

Found is also a siloed platform. It does weight loss well, but if you have other health needs, you'll be managing separate providers elsewhere — which adds both friction and cost.

The "which program gets better patient outcomes" framing is worth addressing directly, because the evidence on coaching add-ons is more nuanced than most platforms let on.

GLP-1 medications like semaglutide and tirzepatide produce clinically significant weight loss through their pharmacological mechanism — full stop. They work by suppressing appetite, slowing gastric emptying, and improving insulin sensitivity. The weight loss data from clinical trials reflects what the medication does, not what the coaching program contributes.

Behavioral support can help patients stay on medication longer, manage side effects, and build habits that support weight maintenance after stopping. But the outcome gap between a well-coached GLP-1 patient and a minimally-supported one is smaller than premium platforms tend to suggest in their marketing.

What actually moves the needle for most patients:

• Getting on the right medication at the right dose with proper provider oversight
• Managing side effects early so you don't quit prematurely
• Having access to ongoing provider follow-up when your needs change
• Keeping costs sustainable so you stay on the program long enough to see results

A $300-per-month coaching program that leads patients to discontinue after three months due to cost pressure produces worse real-world outcomes than a lower-cost program someone can actually afford to stay on for a year.

Gallup data from August 2026 shows that 11% of Americans are currently on a GLP-1 medication. That's a meaningful share of the adult population, and it's reshaped the competitive landscape considerably. A U.S. News roundup published August 12, 2026 counted 23 telehealth providers competing in the GLP-1 category.

With that many options, patients are getting more discerning. The July 2026 JAMA and Yale secret shopper study on telehealth prescribing practices drew significant public attention by documenting lax prescribing standards at some platforms. Patients are now asking harder questions about provider credentials, clinical oversight, and whether a board-certified physician is actually reviewing their intake — or whether it's a checkbox process.

That scrutiny is appropriate. A platform that processes prescriptions without rigorous provider review isn't just a bad value. It's a safety concern.

If you were comparing Found and Calibrate because you wanted a GLP-1 program that felt medically credible — not just a prescription vending machine — you were asking the right questions. Here's what to prioritize when evaluating any platform:

Board-certified provider review. Your intake should be reviewed by a licensed, board-certified clinician. Confirm this before you submit payment.

HIPAA-compliant infrastructure. Your health data is sensitive. The platform should explicitly state HIPAA compliance, not just imply it.

Ongoing provider follow-up. A single intake review isn't enough. Dosing adjustments, side effect management, and treatment changes require continued provider access over time.

No insurance dependency. Calibrate's closure illustrated exactly what happens when a program is built around insurance coverage that can disappear overnight. A cash-pay platform with transparent access is more stable.

Discreet, reliable shipping. If your medication doesn't arrive on schedule, your treatment is interrupted. Confirm the platform ships to your state and that delivery is consistent.

Scope beyond one condition. If you're focused on weight loss now but may have other health needs down the road, a platform that covers multiple categories under one provider relationship saves you from managing a patchwork of telehealth accounts.

JoeyMed is a U.S. telehealth platform covering GLP-1 weight loss, sexual health, wellness and longevity, and travel wellness kits — all under one provider relationship. It's built for the cash-pay patient who wants clinical quality without insurance involvement and without the waitlists that come with traditional primary care.

The process is simple. You complete an online health intake form, a board-certified provider reviews it and approves a personalized treatment plan, and your prescription ships discreetly to your home with free shipping. No insurance required at any step. The platform is HIPAA-compliant, and 24/7 customer support is included alongside ongoing provider follow-up.

GLP-1 options include the GLP-1 Core Plan, the GLP-1 Plus Core Plan, and Tirz HD — a high-dose tirzepatide formulation. An Anti-Nausea add-on is available for patients managing GLP-1 side effects, which is a practical detail that reflects real clinical thinking rather than a one-size-fits-all approach.

What distinguishes JoeyMed from Found specifically is scope and continuity. Found is a weight loss platform. JoeyMed covers weight loss, ED treatment (sildenafil and tadalafil), hair growth, NAD+ and MICC B12 injections, and travel wellness kits. If you're managing more than one health priority, consolidating under one platform with one provider relationship is meaningfully simpler than juggling multiple accounts.

Promotional discounts of up to 50% off are available. For current pricing, visit JoeyMed directly.

Found (2026): Still operating. No insurance required. GLP-1 access with board-certified Rx. Coaching included. Price range $199–$300+/mo. No multi-category care. Nationwide shipping — check site.

Calibrate: No longer operating (closed 2025). Insurance was core to its model. GLP-1 was available. Coaching was included. Pricing is no longer applicable. No multi-category care. No longer shipping.

What to Look For: Active platform. Cash-pay access. Board-certified Rx. Ongoing follow-up. Fits your budget. One provider relationship. Nationwide access.

Calibrate is gone. Found is a legitimate option for patients who want structured coaching alongside GLP-1 medication and can afford the pricing. But the comparison that matters in 2026 isn't Found vs Calibrate — it's Found vs a broader field of telehealth platforms that have improved significantly in clinical rigor, accessibility, and scope.

If you're a cash-pay patient who wants board-certified provider oversight, no insurance involvement, and the ability to address more than just weight loss through one platform, the market has better options than it did two years ago. Verify credentials, confirm HIPAA compliance, and choose a platform you can actually afford to stay on long enough to see results.

Is Calibrate still accepting new patients in 2026? No. Calibrate discontinued operations in 2025 and is no longer accepting patients, processing prescriptions, or offering coaching of any kind. Patients who were enrolled at the time of closure had to seek care elsewhere.

What happened to Calibrate's patients when it shut down? Active patients had their prescriptions interrupted and coaching relationships ended abruptly. It highlighted the real risk of programs built around insurance coverage — benefits that employers or insurers can pull without notice.

Does Found require insurance for GLP-1 medications? Found operates as a cash-pay platform and doesn't require insurance. That said, injectable GLP-1 programs run $300 or more per month, placing it at the higher end of the out-of-pocket market.

What should I look for in a GLP-1 telehealth platform now that Calibrate is closed? Prioritize board-certified provider review, HIPAA-compliant infrastructure, ongoing follow-up beyond the initial intake, cash-pay access without insurance dependency, and reliable nationwide shipping. The July 2026 JAMA and Yale study on telehealth prescribing practices is worth reading if you want to understand what separates credible platforms from lower-quality ones.

How does Found compare to other GLP-1 telehealth platforms in 2026? Found is a solid choice for patients who want structured behavioral coaching alongside medication. Its pricing is higher than several competitors. Platforms like JoeyMed offer GLP-1 programs with board-certified oversight, HIPAA compliance, and free discreet shipping at a cash-pay price point — with the added benefit of covering multiple health categories under one provider relationship.

Can I get tirzepatide through a telehealth platform without insurance? Yes. Several telehealth platforms, including JoeyMed, offer tirzepatide-based GLP-1 programs on a cash-pay basis. Eligibility is determined by a board-certified provider after reviewing your health intake form. Approval depends on your individual health profile and is not guaranteed.

Is a GLP-1 coaching program necessary for weight loss results? Clinical evidence shows that GLP-1 medications produce significant weight loss through their pharmacological mechanism, independent of coaching. Behavioral support can improve adherence and habit formation, but the most important factors for real-world outcomes are staying on the right medication at the right dose, catching side effects early, and keeping costs low enough to remain on the program long-term.